Post-SARS-CoV-2 vaccination specific antibody decrease : Let's get the half-full glass perspective.
作者信息
Béné Marie C, Bittencourt Marcelo de Carvalho, Chevallier Patrice
机构信息
Hematology Biology, Nantes University Hospital, Nantes, France; CRCINA, Inserm, Nantes, France.
Immunology Laboratory, Nancy University Hospital, Nancy, France; CNRS UMR 7365, IMoPA, Université de Lorraine, Nancy, France.
出版信息
J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.07.027. Epub 2021 Jul 29.
Abstract
摘要
相似文献
1
Post-SARS-CoV-2 vaccination specific antibody decrease : Let's get the half-full glass perspective.
J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.07.027. Epub 2021 Jul 29.
2
SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies.
Diagn Microbiol Infect Dis. 2022 Jan;102(1):115565. doi: 10.1016/j.diagmicrobio.2021.115565. Epub 2021 Oct 2.
3
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.
Front Immunol. 2021 Oct 4;12:726960. doi: 10.3389/fimmu.2021.726960. eCollection 2021.
4
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
BMC Med. 2021 Aug 23;19(1):208. doi: 10.1186/s12916-021-02090-6.
5
Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Front Immunol. 2021 Jun 30;12:690698. doi: 10.3389/fimmu.2021.690698. eCollection 2021.
6
Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL).
Viruses. 2021 Nov 23;13(12):2336. doi: 10.3390/v13122336.
7
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases.
Ann Rheum Dis. 2021 Oct;80(10):1312-1316. doi: 10.1136/annrheumdis-2021-220461. Epub 2021 May 6.
8
Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won.
Kidney Int. 2021 Jun;99(6):1494-1496. doi: 10.1016/j.kint.2021.04.010. Epub 2021 Apr 20.
9
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.
EBioMedicine. 2021 Aug;70:103523. doi: 10.1016/j.ebiom.2021.103523. Epub 2021 Aug 12.
10
Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection.
Viruses. 2021 Oct 5;13(10):2003. doi: 10.3390/v13102003.
引用本文的文献
1
B Cell Aplasia Is the Most Powerful Predictive Marker for Poor Humoral Response after BNT162b2 mRNA SARS-CoV-2 Vaccination in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Transplant Cell Ther. 2022 May;28(5):279.e1-279.e4. doi: 10.1016/j.jtct.2022.02.018. Epub 2022 Feb 24.
Zotero 插件